- Record: found
- Abstract: not found
- Article: not found
Zur Behandlung von Typ-II-Diabetikern mit Sulphonylharnstoff-Sekundärversagen-Kombinationstherapie mit Glibenclamid und Insulin. 3. Komplementäre Insulintherapie in kleinen Dosen (Treatment of type 2 diabetics (non-insulin-dependent) for sulphonylurea secondary failure—combined therapy, using glibenclamid and insulin. 3. Complementary small insulin boluses.)
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.